Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.

New here? Stop in and introduce yourself. Where you are, what you work on, etc.

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-21-2011, 08:25 PM
16 responses
54,605 views
0 likes
Last Post Guest's Avatar
by Guest
 
Started by Rogue, 07-14-2011, 01:54 AM
0 responses
1,191 views
0 likes
Last Post Rogue
by Rogue
 
Started by jhw30103, 07-13-2011, 05:01 PM
0 responses
1,659 views
0 likes
Last Post jhw30103  
Started by BSH, 07-12-2011, 12:10 PM
0 responses
2,420 views
0 likes
Last Post BSH
by BSH
 
Started by snail813, 07-05-2011, 06:00 PM
0 responses
1,630 views
0 likes
Last Post snail813  
Started by kkizhatil, 07-05-2011, 07:32 AM
0 responses
1,809 views
0 likes
Last Post kkizhatil  
Started by kkizhatil, 07-05-2011, 07:30 AM
0 responses
1,595 views
0 likes
Last Post kkizhatil  
Started by zianeffy, 07-04-2011, 02:29 PM
0 responses
2,887 views
0 likes
Last Post zianeffy  
Started by rishistar, 07-04-2011, 11:05 AM
0 responses
3,041 views
0 likes
Last Post rishistar  
Started by markero, 06-30-2011, 05:10 AM
5 responses
2,606 views
0 likes
Last Post jstjohn
by jstjohn
 
Started by rworthi, 06-18-2011, 08:38 AM
4 responses
3,607 views
0 likes
Last Post scordes
by scordes
 
No topics found.
  • Filter
  • Time
Clear All

Webinars

Collapse

  • seqadmin
    On-Demand Webinars
    by seqadmin
    This fall was packed with four must-see webinars! If you missed out, they’re all available on demand for you to watch at your convenience.

    ...
    11-04-2024, 08:07 AM

Recent Articles

Collapse

  • seqadmin
    Recent Advances in Sequencing Technologies
    by seqadmin



    Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

    Long-Read Sequencing
    Long-read sequencing has seen remarkable advancements,...
    12-02-2024, 01:49 PM
  • seqadmin
    Genetic Variation in Immunogenetics and Antibody Diversity
    by seqadmin



    The field of immunogenetics explores how genetic variations influence immune responses and susceptibility to disease. In a recent SEQanswers webinar, Oscar Rodriguez, Ph.D., Postdoctoral Researcher at the University of Louisville, and Ruben Martínez Barricarte, Ph.D., Assistant Professor of Medicine at Vanderbilt University, shared recent advancements in immunogenetics. This article discusses their research on genetic variation in antibody loci, antibody production processes,...
    11-06-2024, 07:24 PM
  • seqadmin
    Choosing Between NGS and qPCR
    by seqadmin



    Next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR) are essential techniques for investigating the genome, transcriptome, and epigenome. In many cases, choosing the appropriate technique is straightforward, but in others, it can be more challenging to determine the most effective option. A simple distinction is that smaller, more focused projects are typically better suited for qPCR, while larger, more complex datasets benefit from NGS. However,...
    10-18-2024, 07:11 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 12-02-2024, 09:29 AM
0 responses
155 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-02-2024, 09:06 AM
0 responses
51 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-02-2024, 08:03 AM
0 responses
44 views
0 likes
Last Post seqadmin  
Working...
X